Hubei Jumpcan Pharmaceutical Co., LtdSSE: 600566

Announcement on Progress in Repurchasing Shares through Call Auction

May 8, 2026 · Issued by Hubei Jumpcan Pharmaceutical Co., Ltd via Shanghai Stock Exchange

Filed with SSE · May 8, 2026 · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-progress-in-repurchasing-shares-through-call-auction-19

Release

Announcement on Progress in Repurchasing Shares through Call Auction

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Hubei Jumpcan Pharmaceutical Co., Ltd on 6ix

Earlier from Hubei Jumpcan Pharmaceutical

Announcement on Receipt of Drug Registration Application Acceptance NoticeApr 28
Announcement on Resolutions of the 20th Meeting of the 10th Board of DirectorsApr 24
Announcement on Self-exercise Results and Changes in Share Capital of 2022 Restricted Stock and Stock Option Incentive Plan in Q1 2026Apr 2
Announcement on Progress in Wholly-owned Subsidiary Using Idle Raised Funds for Cash ManagementMar 7
Indicative Announcement on Expiration of Term of Certain Independent DirectorsFeb 28

Later from Hubei Jumpcan Pharmaceutical

Indicative Announcement on Convening the 2025 Annual General MeetingMay 9
Announcement on Resolutions of the 2025 Annual General MeetingMay 16
Announcement on Approval of Pudilan Xiaoyan Oral Liquid as a National Protected Traditional Chinese Medicine VarietyMay 18
Indicative Announcement on Expiration of the 2nd Lock-up Period of 2024 Employee Stock Ownership PlanMay 23
Indicative Announcement on Restricted Exercise Period for the Stock Options Initially Granted in 2022 Restricted Stock and Stock Option Incentive PlanMay 28

All Hubei Jumpcan Pharmaceutical news releases

Follow Hubei Jumpcan Pharmaceutical into a list and get an email when it puts out news.

Follow Hubei Jumpcan Pharmaceutical